HYPERMETABOLISM OF PHENYTOIN AS A CAUSE OF TREATMENT FAILURE

被引:3
作者
LEBRUN, LH
VILLENEUVE, JP
机构
[1] HOP ST LUC,CLIN RES CTR,DEPT MED,MONTREAL H2X 3J4,QUEBEC,CANADA
[2] UNIV MONTREAL,MONTREAL H3C 3J7,QUEBEC,CANADA
关键词
D O I
10.1097/00002826-198303000-00008
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:67 / 70
页数:4
相关论文
共 10 条
  • [1] BIRCHER J, 1976, CLIN PHARMACOL THER, V20, P484
  • [2] BRANCH RA, 1976, CLIN PHARMACOL THER, V20, P81
  • [3] GUGLER R, 1976, CLIN PHARMACOL THER, V19, P135
  • [4] HAWKINS DW, 1976, NEUROLOGY, V26, P343
  • [5] LUDDEN TM, 1977, CLIN PHARMACOL THER, V21, P287
  • [6] PHENYTOIN DOSE ADJUSTMENT IN EPILEPTIC PATIENTS
    MAWER, GE
    MULLEN, PW
    RODGERS, M
    ROBINS, AJ
    LUCAS, SB
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1974, 1 (02) : 163 - 168
  • [7] RICHENS A, 1975, LANCET, V2, P247
  • [8] SOLDIN SJ, 1976, CLIN CHEM, V22, P856
  • [9] VANDERKLEIJN E, 1975, CLIN PHARM ANTIEPILE, P11
  • [10] INHERITANCE OF PHENYTOIN HYPO-METABOLISM - KINETIC-STUDY OF ONE FAMILY
    VASKO, MR
    BELL, RD
    DALY, DD
    PIPPENGER, CE
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (01) : 96 - 103